High-tech will improve radiotherapy of NSCLC: A hypothesis waiting to be validated

This publication has 33 references indexed in Scilit:

• The impact of 18 FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study
  International Journal of Radiation Oncology*Biology*Physics, 2002
• F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma
  Cancer, 2001
• CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Use of PET to monitor the response of lung cancer to radiation treatment
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
  Radiotherapy and Oncology, 2000
• Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
  Chest, 2000
• 18F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects
  Lung Cancer, 1999
• The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1
  Lung Cancer, 1998
• Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group
  Cancer, 1987